These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 26971226)
41. Expression and switching of TH1/TH2 type cytokines gene in human gliomas. Li G; Hu YS; Li XG; Zhang QL; Wang DH; Gong SF Chin Med Sci J; 2005 Dec; 20(4):268-72. PubMed ID: 16422258 [TBL] [Abstract][Full Text] [Related]
42. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response. Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016 [TBL] [Abstract][Full Text] [Related]
43. Expression and clinical role of RBQ3 in gliomas. Zhao C; Chen W; Dai S; Zhang X; Ban N; Fan S; Bao Z; Sun J; Shen C; Xia X; Zhang L; Ren J J Neurol Sci; 2015 Dec; 359(1-2):177-84. PubMed ID: 26671109 [TBL] [Abstract][Full Text] [Related]
44. Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. Huang YS; Chang CC; Lee SS; Jou YS; Shih HM Oncotarget; 2016 Jul; 7(28):43256-43266. PubMed ID: 27248326 [TBL] [Abstract][Full Text] [Related]
45. Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients. Ueda R; Yoshida K; Kawase T; Kawakami Y; Toda M Int J Cancer; 2007 Apr; 120(8):1704-11. PubMed ID: 17230535 [TBL] [Abstract][Full Text] [Related]
46. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas. Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886 [TBL] [Abstract][Full Text] [Related]
47. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944 [TBL] [Abstract][Full Text] [Related]
48. Downregulation of nitrogen permease regulator like-2 activates PDK1-AKT1 and contributes to the malignant growth of glioma cells. Huang N; Cheng S; Mi X; Tian Q; Huang Q; Wang F; Xu Z; Xie Z; Chen J; Cheng Y Mol Carcinog; 2016 Nov; 55(11):1613-1626. PubMed ID: 26455908 [TBL] [Abstract][Full Text] [Related]
49. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas. Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594 [TBL] [Abstract][Full Text] [Related]
50. Tristetraprolin exerts tumor suppressive functions on the tumorigenesis of glioma by targeting IL-13. Zeng B; Zhu D; Su Z; Li Z; Yu Z Int Immunopharmacol; 2016 Oct; 39():63-70. PubMed ID: 27424080 [TBL] [Abstract][Full Text] [Related]
51. Lower expression of PH domain leucine-rich repeat protein phosphatase 1 (PHLPP1) association with poor prognosis of gastric cancer. Hou Y; Deng J; Zhang L; Xie X; Guo X; Sun C; Zhang R; Liang H Int J Clin Exp Med; 2015; 8(11):20481-9. PubMed ID: 26884964 [TBL] [Abstract][Full Text] [Related]
52. Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer. Baffi TR; Van AN; Zhao W; Mills GB; Newton AC Mol Cell; 2019 Apr; 74(2):378-392.e5. PubMed ID: 30904392 [TBL] [Abstract][Full Text] [Related]
54. Insilico modeling and analysis of small molecules binding to the PHLPP1 protein by molecular dynamics simulation. Anwar T; Ul Hasnain MJ; Sarwar A; Kanwal H; Afzal B; Babar ME; Parvez MT Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):287-294. PubMed ID: 32122860 [TBL] [Abstract][Full Text] [Related]
55. Glioma cells are resistant to inflammation‑induced alterations of mitochondrial dynamics. Fan W; Song Y; Ren Z; Cheng X; Li P; Song H; Jia L Int J Oncol; 2020 Dec; 57(6):1293-1306. PubMed ID: 33174046 [TBL] [Abstract][Full Text] [Related]
56. Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation. Zhou W; Jiang Z; Li X; Xu Y; Shao Z J Cancer Res Clin Oncol; 2015 Apr; 141(4):575-89. PubMed ID: 25005789 [TBL] [Abstract][Full Text] [Related]
57. The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. Kawashima AT; Wong C; Lordén G; King CC; Lara-Gonzalez P; Desai A; Gingras AC; Newton AC Mol Cell Biol; 2021 Feb; 41(3):e0033320. PubMed ID: 33397691 [TBL] [Abstract][Full Text] [Related]
58. Antibody crossreactivity between the tumour suppressor PHLPP1 and the proto-oncogene β-catenin. Lobert VH; Bruun J; Abrahamsen H; Lothe RA; Stenmark H; Kolberg M; Campsteijn C EMBO Rep; 2013 Jan; 14(1):10-1. PubMed ID: 23229585 [No Abstract] [Full Text] [Related]
59. PHLPP1 is a metastasis suppressor in melanoma. Dai M; Yu Y Aging (Albany NY); 2018 Sep; 10(9):2214-2215. PubMed ID: 30187888 [No Abstract] [Full Text] [Related]
60. Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor. Park J; Lee H; Tran Q; Mun K; Kim D; Hong Y; Kwon SH; Brazil D; Park J; Kim SH Toxicol Res; 2017 Jan; 33(1):63-69. PubMed ID: 28133515 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]